Daniel D. Long, SVP, Drug Discovery at Septerna, Inc. (SEPN), sold 3,334 shares at $33.98 ($115K) on 2026-08-03, disclosed to the SEC on 2026-08-05.
Scheduled sale ($115k) by SVP, Drug Discovery under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.98 | 1,000 | $34K | 29.6% |
| 2 | $34.68 | 2,334 | $81K | 70.4% |
| Total | $34.47 avg | 3,334 | $115K | 100% |
| Filing → |
| SEPN | SELL | 2026-06-24 | $533K | — | Filing → |
| SEPN | SELL | 2025-11-13 | $126K | — | Filing → |